MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
49.55
-3.86 (-7.23%)
Nov 20, 2026, 4:00 PM EST - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $2.46 billion as of November 20, 2026. It is the 5,474th most valuable company in the world and the 1,584th biggest in the United States. Its market cap has increased by 100.06% in one year.
Market Cap
2.46B
Enterprise Value
1.98B
1-Year Change
100.06%
Global Rank
Country Rank
#1,584 United States
Category
ChartMarket Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $2.46B, an increase of 382.77%. That is a compound annual growth rate of 105.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.46B | 73.74% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 (IPO) | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 3.03B |
| Dyne Therapeutics | 3.00B |
| Telix Pharmaceuticals | 3.00B |
| Vericel | 2.97B |
| ADMA Biologics | 2.96B |
| Denali Therapeutics | 2.92B |
| Celcuity | 2.77B |
| Xencor | 2.55B |